Exciting outcomes from the STEP TEENS trial were presented at ObesityWeek 2022 and simultaneously published in the New England Journal of Medicine. The outcomes of the phase 3 study indicate that adolescents with obesity benefit from once-weekly injection semaglutide over placebo. With over 100 sessions, ObesityWeek 2022 is the largest international conference on obesity, coinciding … Continue reading ObesityWeek 2022: Semaglutide Shows Promise in Adolescents